These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 22199370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Smoothelin-B is not a target of matrix metalloproteinase (MMP)-2 in the vasculature of endotoxemic rats.
    de Souza P, Mazzaron de Castro M, Goobie G, da Silva-Santos JE, Schulz R.
    Can J Physiol Pharmacol; 2014 Oct; 92(10):887-91. PubMed ID: 25272092
    [Abstract] [Full Text] [Related]

  • 3. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
    Parente JM, Pereira CA, Oliveira-Paula GH, Tanus-Santos JE, Tostes RC, Castro MM.
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.
    Lalu MM, Cena J, Chowdhury R, Lam A, Schulz R.
    Br J Pharmacol; 2006 Sep; 149(1):31-42. PubMed ID: 16880766
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension.
    Belo VA, Parente JM, Tanus-Santos JE, Castro MM.
    Biochem Pharmacol; 2016 Oct 15; 118():50-58. PubMed ID: 27531060
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase inhibitors prevent sepsis-induced refractoriness to vasoconstrictors in the cecal ligation and puncture model in rats.
    de Souza P, Schulz R, da Silva-Santos JE.
    Eur J Pharmacol; 2015 Oct 15; 765():164-70. PubMed ID: 26297976
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
    Chew DK, Conte MS, Khalil RA.
    J Vasc Surg; 2004 Nov 15; 40(5):1001-10. PubMed ID: 15557917
    [Abstract] [Full Text] [Related]

  • 11. Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta.
    Farmer MR, Roberts RE, Gardiner SM, Ralevic V.
    J Pharmacol Exp Ther; 2003 Aug 15; 306(2):538-45. PubMed ID: 12730359
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
    Buduneli E, Vardar-Sengül S, Buduneli N, Atilla G, Wahlgren J, Sorsa T.
    J Periodontol; 2007 Jan 15; 78(1):127-34. PubMed ID: 17199549
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-lβ induces migration of rat arterial smooth muscle cells through a mechanism involving increased matrix metalloproteinase-2 activity.
    Wang Z, Kong L, Kang J, Vaughn DM, Bush GD, Walding AL, Grigorian AA, Robinson JS, Nakayama DK.
    J Surg Res; 2011 Aug 15; 169(2):328-36. PubMed ID: 20371087
    [Abstract] [Full Text] [Related]

  • 14. Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors.
    Fugler LA, Eades SC, Moore RM, Koch CE, Keowen ML.
    Am J Vet Res; 2013 Mar 15; 74(3):473-80. PubMed ID: 23438126
    [Abstract] [Full Text] [Related]

  • 15. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure.
    Grandas OH, Mountain DH, Kirkpatrick SS, Cassada DC, Stevens SL, Freeman MB, Goldman MH.
    J Vasc Surg; 2009 Jan 15; 49(1):185-91. PubMed ID: 18829229
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
    Lalu MM, Gao CQ, Schulz R.
    Mol Cell Biochem; 2003 Sep 15; 251(1-2):61-6. PubMed ID: 14575305
    [Abstract] [Full Text] [Related]

  • 17. Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension.
    de Oliveira Neves VG, Blascke de Mello MM, Rodrigues D, Pernomian L, de Oliveira IS, Parente JM, Arantes EC, Tostes RC, Castro MM.
    Vascul Pharmacol; 2023 Oct 15; 152():107211. PubMed ID: 37607602
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.
    Castro MM, Fuah J, Ali M, Sung M, Schulz J, Kondo MY, Fan X, Holt A, Schulz R.
    Biochem Pharmacol; 2013 Aug 15; 86(4):469-75. PubMed ID: 23774623
    [Abstract] [Full Text] [Related]

  • 19. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
    Ismailoglu UB, Pekiner C, Yorganci K, Sahin-Erdemli I.
    Eur J Surg; 2001 Nov 15; 167(11):803-9. PubMed ID: 11848232
    [Abstract] [Full Text] [Related]

  • 20. [Melatonin improves vascular reactivity of endotoxemia rats].
    Xing HY, Ling YL, Meng AH, Zhao XY, Huang XL.
    Sheng Li Xue Bao; 2005 Jun 25; 57(3):367-72. PubMed ID: 15968434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.